BMY vs EVI · P/E 17, rev $24.46B vs P/E 35, rev $389.8M
Bristol-Myers Squibb Company (BMY) versus EVI Industries Inc (EVI) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
EVI Industries Inc (EVI) is a industrial distribution company listed on AMEX.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported EVI revenue for 2025-06-30 was $389.8M. Net income was $7.5M. EVI currently screens at market cap $202.8M and trailing P/E 35.0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. EVI currently screens at market cap $202.8M and trailing P/E 35.0.
Not investment advice. Open the BMY and EVI stock pages for the full models.
Not investment advice.